Heparin dosing and monitoring for cardiopulmonary bypass
- 1 March 1990
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 99 (3) , 518-527
- https://doi.org/10.1016/s0022-5223(19)36983-1
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Early Anticoagulation Peak and Rapid Distribution After Intravenous HeparinAnesthesiology, 1988
- Hemostasis Changes During Cardiopulmonary Bypass SurgerySeminars in Thrombosis and Hemostasis, 1985
- Biochemical and Pharmacologic Studies on the Protamine Interactions with Heparin, Its Fractions and FragmentsSeminars in Thrombosis and Hemostasis, 1985
- Heparin, Its Fractions, Fragments and Derivatives Some Newer PerspectivesSeminars in Thrombosis and Hemostasis, 1985
- Performance Characteristics of a Simple Radioimmunoassay for Fibrinopeptide ASeminars in Thrombosis and Hemostasis, 1984
- Heparin Monitoring and Neutralization during Cardiopulmonary Bypass Using a Rapid Plasma Separator and a Fluorometric AssayThe Annals of Thoracic Surgery, 1984
- Monitoring Heparin Anticoagulation and Its NeutralizationThe Annals of Thoracic Surgery, 1981
- Lack of Correlation Between Activated Clotting Time and Plasma Heparin During Cardiopulmonary BypassAnnals of Surgery, 1981
- Elevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass.Circulation, 1980
- Measurement of Fibrinopeptide A in Human BloodJournal of Clinical Investigation, 1974